Growth hormone treatment improves final height in children with X-linked hypophosphatemia.
Julia AndréVolha V ZhukouskayaAnne-Sophie LambertJean-Pierre SallesBrigitte MignotClaire BardetCatherine ChaussainAnya RothenbuhlerAgnès LinglartPublished in: Orphanet journal of rare diseases (2022)
Treatment with rhGH permits to improve final height in children with XLH and growth failure, despite optimal conventional treatment. We propose therefore that rhGH therapy could be considered as an option for short stature in the context of XLH.